Selected Publication:
SHR
Neuro
Cancer
Cardio
Lipid
Metab
Microb
Heitzer, E; Lax, S; Lafer, I; Müller, SM; Pristauz, G; Ulz, P; Jahn, S; Högenauer, C; Petru, E; Speicher, MR; Geigl, JB.
Multiplex genetic cancer testing identifies pathogenic mutations in TP53 and CDH1 in a patient with bilateral breast and endometrial adenocarcinoma.
BMC Med Genet. 2013; 14(1):129-129
Doi: 10.1186/1471-2350-14-129
(- Case Report)
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
- Leading authors Med Uni Graz
-
Geigl Jochen Bernd
-
Heitzer Ellen
- Co-authors Med Uni Graz
-
Hoegenauer Christoph
-
Jahn Stephan
-
Lafer Ingrid
-
Müller Stephanie Martha
-
Petru Edgar
-
Pristauz-Telsnigg Gunda
-
Speicher Michael
-
Ulz Peter
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Scite (citation analytics):
- Abstract:
-
Germline genetic testing for familial cancer syndromes is usually performed serially for the most likely genetic causes. In recent years the way genetic testing carried out has changed, as next generation sequencing now allows the simultaneous testing of multiple susceptibility genes at low costs.
Here, we present a female with bilateral breast cancer and endometrial adenocarcinoma. After simultaneous sequencing of 150 genes (890 kb) associated with hereditary cancer we identified pathogenic mutations in two high-penetrance genes, i.e. TP53 and CDH1 that would most likely not have been elucidated by serial screening of candidate genes.
As the two mutated genes are located on different chromosomes and cause different cancer syndromes these findings had a tremendous impact not only on genetic counseling of the index patient and her family but also on subsequent surveillance strategies.
- Find related publications in this database (using NLM MeSH Indexing)
-
Adenocarcinoma - genetics
-
Breast Neoplasms - genetics
-
Cadherins - genetics
-
Endometrial Neoplasms - genetics
-
Female -
-
Genetic Testing - methods
-
Humans -
-
Male -
-
Middle Aged -
-
Mutation -
-
Pedigree -
-
Tumor Suppressor Protein p53 - genetics
- Find related publications in this database (Keywords)
-
Multiplex genetic testing
-
Cancer susceptibility
-
TP53
-
CDH1
-
Next generation sequencing
-
NGS